A hermeneutic phenomenological study of why adults with type 1 diabetes choose to discontinue CSII
DOI:
https://doi.org/10.1002/edn.167Keywords:
CSII, discontinuing, type 1 diabetesAbstract
AbstractThis qualitative study was designed to examine why people with type 1 diabetes choose to discontinue continuous subcutaneous insulin infusion (CSII). The sample consisted of five adult participants with type 1 diabetes who had already taken the decision to discontinue CSII. Data were collected using audio taped, semi-structured interviews. Tapes were transcribed and analysed using a thematic analysis. Three themes emerged: (1) the challenges of wearing the pump, (2) lack of control over the pump, body and health, and (3) comparing expectations versus reality. Results are of relevance to people with diabetes, those professionals referring, commissioning and providing a service, and manufacturers.
Downloads
References
Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25 ( 3) :593–8.
Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century: Strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med 2002;111 ( 5) :69–77.
Hanas It Type 1 diabetes in children, adolescents and young adults. How to become an expert on your own diabetes, 3rd edn. London: Class publishing, 2006.
Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996;19:324–7.
Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003; 26(4):1079–87.
Barnard KD, Speight J, Skinner TC. Quality of life and impact of continuous subcutaneous insulin infusion for children and their parents. Pract Diabetes Int 2008; 25(7)278–84.
Barnard KD, Skinner, TC. Qualitative study into quality of life issues surrounding insulin pump use in type 1 diabetes. Pract Diabetes Int 2007;24 (3)143–8.
Ritholz MD, Smaldone A, Lee J, et al. Perceptions of psychosocial factors and the insulin pump. Diabetes Care 2007;30:549–54.
Guinn TS, Bailey GJ, Mechlenburg RS. Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy. Diabetes Care 1988;11 (1) 46–51.
Bell D, Ackerson C, Cutter G, et al. Factors associated with discontinuation of continuous subcutaneous insulin infusion. Am J Med Sci 1988;295:23–8.
Garmo A,Pettersson-Frank B,Ehrenberg A. Treatment effects and satisfaction in diabetic patients changing from multiple daily insulin injections to CSII. Pract Diabetes Int 2004;21 (1 ) : 7–12.
Karagiahnni P, Sampanis Ch, Katsoulis C, et al Continuous subcutaneous insulin infusion versus multiple daily injections. Hippokratia 2009;13 (2) 93–6.
Wolf FM, Jacober SJ, Wolf L, et al. Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus. J Clin Epidemiol 1989;42:1129–36.
National Institute for Health and Clinical Excellence. Continuous insulin infusion for the treatment of diabetes mellitus. Review of technology appraisal guidance 57. NICE technology appraisal guidance 151. London: NICE, 2008.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2011 FEND
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
